89bio stock falls following public offering announcement
Shares of 89bio, Inc. (NASDAQ:ETNB) tumbled 6% after the company announced its plans for an underwritten public offering of common stock and pre-funded warrants. The clinical-stage biopharmaceutical company,
Annovis Bio, Inc. Announces Pricing of $21 Million Public Offering
MALVERN, Pa., Feb. 03, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical
Butterfly Network Announces Pricing of $75.6 million Public Offering of Common Stock
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ult
BriaCell announces public offering of common shares
PHILADELPHIA and VANCOUVER, British Columbia - BriaCell Therapeutics Corp., a clinical-stage biotechnology company specializing in immunotherapies for cancer care, announced today its plans to conduct a best-efforts public offering of common shares.
GH Research Announces Proposed Public Offering
GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today announced the commencement of an underwritten public offering in the United States of $150 million of ordinary shares.
Decent Holding Inc. Announces Pricing of Initial Public Offering
Decent Holding Inc. (the “Company”), an established wastewater treatment services provider in China, today announced the pricing of its initial public offering (the “Offering”) of 1,250,000 ordinary shares (the “Ordinary Shares”) at a public offering price of $4.
Morningstar5d
Immunome Announces Proposed Public Offering of Common Stock
In connection with the proposed offering, Immunome expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public ...
Nasdaq6d
Akero Therapeutics Announces Pricing of Upsized Public Offering for $350 Million
Akero Therapeutics announced a public offering of over 5.3 million shares at $48 each, aiming for $350 million in proceeds. Akero Therapeutics, Inc. has announced a public offering of 5,333,420 ...
Vertical Aerospace Announces Launch of Proposed Underwritten Public Offering
Vertical Aerospace (Vertical) (NYSE: EVTL) ("Vertical" or the "Company"), a global aerospace and technology company that is ...
Business Wire3d
Atlas Energy Solutions Announces Pricing of Upsized Underwritten Public Offering of Common Stock
Atlas Energy Solutions Inc. (NYSE: AESI) (“Atlas” or the “Company”) today announced the pricing of an upsized underwritten public offering (the “Offer ...
When Did Facebook (Meta) Go Public?
Facebook (Meta) had one of the largest and most anticipated IPOs in history on May 18, 2012, but it failed to meet expectations. A NASDAQ glitch cost investors.
Morningstar7d
Akero Therapeutics Announces Proposed Public Offering of Common Stock
In addition, Akero intends to grant the underwriters a 30-day option to purchase up to an additional $45.0 million of shares of its common stock at the public offering price, less underwriting ...